These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 6112267)

  • 21. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
    Augustine GJ; Levitan H
    J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The kinetics of quantal releases during end-plate currents at the frog neuromuscular junction.
    Van der Kloot W
    J Physiol; 1988 Aug; 402():605-26. PubMed ID: 2853224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of changes in motor unit size on transmitter release at the frog neuromuscular junction.
    Herrera AA; Grinnell AD
    J Neurosci; 1985 Jul; 5(7):1896-900. PubMed ID: 2862227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantal independence and uniformity of presynaptic release kinetics at the frog neuromuscular junction.
    Barrett EF; Stevens CF
    J Physiol; 1972 Dec; 227(3):665-89. PubMed ID: 4405552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantal parameters of transmission at the frog neuromuscular junction.
    Volle RL; Branisteanu DD
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Nov; 295(2):103-8. PubMed ID: 186720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetanic stimulation increases the frequency of miniature end-plate potentials at the frog neuromuscular junction in Mn2+-, CO2+-, and Ni2+-saline solutions.
    Kita H; Narita K; Van der Kloot W
    Brain Res; 1981 Jan; 205(1):111-21. PubMed ID: 6258705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual effect of calmidazolium (R 24571) on transmitter release at the frog neuromuscular junction.
    Sahaf ZY; Publicover SJ
    Brain Res; 1985 Nov; 348(1):192-6. PubMed ID: 2998560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between quantal secretion and vesicle loss at the frog neuromuscular junction.
    Hurlbut WP; Iezzi N; Fesce R; Ceccarelli B
    J Physiol; 1990 Jun; 425():501-26. PubMed ID: 2120425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of intracellular Ca2+ in stimulation-induced increases in transmitter release at the frog neuromuscular junction.
    Zengel JE; Sosa MA; Poage RE; Mosier DR
    J Gen Physiol; 1994 Aug; 104(2):337-55. PubMed ID: 7807052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of phorbol ester on spontaneous transmitter release at frog neuromuscular junction.
    Eusebi F; Molinaro M; Caratsch CG
    Pflugers Arch; 1986 Feb; 406(2):181-3. PubMed ID: 2870468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of the larval neuromuscular junction in Drosophila melanogaster.
    Jan LY; Jan YN
    J Physiol; 1976 Oct; 262(1):189-214. PubMed ID: 11339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strontium and quantal release of transmitter at the neuromuscular junction.
    Dodge FA; Miledi R; Rahamimoff R
    J Physiol; 1969 Jan; 200(1):267-83. PubMed ID: 4387376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of physiologic alterations on binomial transmitter release at magnesium-depressed neuromuscular junctions.
    Branisteanu DD; Miyamoto MD; Volle RL
    J Physiol; 1976 Jan; 254(1):19-37. PubMed ID: 175150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in synaptic efficacy at neuromuscular junctions in frog twitch muscles.
    Banner LR; Herrera AA
    J Physiol; 1986 Oct; 379():205-15. PubMed ID: 2882018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of single quantal efficacy at the snake neuromuscular junction.
    Wilkinson RS; Lunin SD; Stevermer JJ
    J Physiol; 1992 Mar; 448():413-36. PubMed ID: 1350638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dependence on multivalent cations of quantal release of transmitter induced by black widow spider venom.
    Misler S; Falke LC
    Am J Physiol; 1987 Sep; 253(3 Pt 1):C469-76. PubMed ID: 2888313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synaptic depression in frog neuromuscular junction.
    Glavinović MI
    J Neurophysiol; 1987 Jul; 58(1):230-46. PubMed ID: 2441003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of quantal secretion induced by ouabain and its correlation with depletion of synaptic vesicles.
    Haimann C; Torri-Tarelli F; Fesce R; Ceccarelli B
    J Cell Biol; 1985 Nov; 101(5 Pt 1):1953-65. PubMed ID: 3932368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
    Volle RL; Branisteanu DD
    J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of a reduction in temperature on the quantal release of transmitter at the mouse neuromuscular junction.
    Nishimura M; Shimizu Y; Satoh E; Yokoyama T; Yagasaki O
    Gen Pharmacol; 1993 Sep; 24(5):1235-9. PubMed ID: 7903651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.